DK1093381T3 - Antigene peptider afledt fra teleromerase - Google Patents

Antigene peptider afledt fra teleromerase

Info

Publication number
DK1093381T3
DK1093381T3 DK99928238T DK99928238T DK1093381T3 DK 1093381 T3 DK1093381 T3 DK 1093381T3 DK 99928238 T DK99928238 T DK 99928238T DK 99928238 T DK99928238 T DK 99928238T DK 1093381 T3 DK1093381 T3 DK 1093381T3
Authority
DK
Denmark
Prior art keywords
teleromerase
peptides derived
antigenic peptides
antigenic
derived
Prior art date
Application number
DK99928238T
Other languages
English (en)
Other versions
DK1093381T4 (da
Inventor
Jon Amund Eriksen
Gustav Gaudernack
Marianne Klemp Gjertsen
Mona Moller
Ingvil Saeterdal
Stein Saeboe-Larsen
Original Assignee
Gemvax As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19902234&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1093381(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gemvax As filed Critical Gemvax As
Application granted granted Critical
Publication of DK1093381T3 publication Critical patent/DK1093381T3/da
Publication of DK1093381T4 publication Critical patent/DK1093381T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001154—Enzymes
    • A61K39/001157—Telomerase or TERT [telomerase reverse transcriptase]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99928238T 1998-07-08 1999-06-30 Antigene peptider afledt fra teleromerase DK1093381T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO19983141A NO313834B1 (no) 1998-07-08 1998-07-08 Telomeraseprotein eller -peptider, nukleinsyresekvenser som koder for disse, farmasöytiske sammensetninger inneholdende disseog fremgangsmÕter for Õ fremstille slike farmasöytiskesammensetninger til profylakse mot og behandling av kreft, samt
PCT/NO1999/000220 WO2000002581A1 (en) 1998-07-08 1999-06-30 Antigenic peptides derived from telomerase

Publications (2)

Publication Number Publication Date
DK1093381T3 true DK1093381T3 (da) 2003-09-08
DK1093381T4 DK1093381T4 (da) 2009-09-21

Family

ID=19902234

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99928238T DK1093381T4 (da) 1998-07-08 1999-06-30 Antigene peptider afledt fra teleromerase
DK03075681T DK1362597T3 (da) 1998-07-08 1999-06-30 Antigene peptider, der er afledt af telomerase

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK03075681T DK1362597T3 (da) 1998-07-08 1999-06-30 Antigene peptider, der er afledt af telomerase

Country Status (20)

Country Link
US (2) US7030211B1 (da)
EP (4) EP2316476B1 (da)
JP (2) JP4618657B2 (da)
CN (1) CN100376290C (da)
AR (2) AR020601A1 (da)
AT (2) ATE458494T1 (da)
AU (1) AU756094B2 (da)
CA (2) CA2336743C (da)
CY (1) CY1109978T1 (da)
CZ (1) CZ303215B6 (da)
DE (2) DE69910580T3 (da)
DK (2) DK1093381T4 (da)
ES (2) ES2341170T5 (da)
HK (1) HK1039068B (da)
HU (1) HU230007B1 (da)
NO (1) NO313834B1 (da)
PL (1) PL203815B1 (da)
PT (2) PT1362597E (da)
TW (1) TWI261617B (da)
WO (1) WO2000002581A1 (da)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475789B1 (en) 1996-10-01 2002-11-05 University Technology Corporation Human telomerase catalytic subunit: diagnostic and therapeutic methods
US7585622B1 (en) 1996-10-01 2009-09-08 Geron Corporation Increasing the proliferative capacity of cells using telomerase reverse transcriptase
DE19743497A1 (de) * 1996-10-01 1998-08-20 Geron Corp Katalytische Untereinheit menschlicher Telomerase
US7413864B2 (en) 1997-04-18 2008-08-19 Geron Corporation Treating cancer using a telomerase vaccine
US7622549B2 (en) 1997-04-18 2009-11-24 Geron Corporation Human telomerase reverse transcriptase polypeptides
AU3456099A (en) 1998-03-31 1999-10-18 Geron Corporation Methods and compositions for eliciting an immune response to a telomerase antigen
US7402307B2 (en) 1998-03-31 2008-07-22 Geron Corporation Method for identifying and killing cancer cells
AU1331100A (en) * 1998-10-29 2000-05-22 Dana-Farber Cancer Institute Cancer immunotheraphy and diagnosis using universal tumor associated antigens, including htert
CA2368967A1 (en) * 1999-04-09 2000-10-19 Biomira, Inc. Telomerase-specific cancer vaccine
WO2001060391A1 (en) 2000-02-15 2001-08-23 Regents Of The University Of California A universal vaccine and method for treating cancer employing telomerase reverse transcriptase
EP1257284A4 (en) * 2000-02-15 2005-12-21 Univ California UNIVERSAL VACCINE AND METHOD OF TREATING CANCER USING TELOMERASE REVERSE TRANSCRIPTASE
FR2812087B1 (fr) 2000-07-21 2007-05-11 Inst Nat Sante Rech Med Procede de criblage de peptides utilisables en immunotherapie
GB0031430D0 (en) * 2000-12-22 2001-02-07 Norsk Hydro As Polypeptides
GB0105238D0 (en) * 2001-03-02 2001-04-18 Norsk Hydro As Vaccines
GB0112342D0 (en) * 2001-05-21 2001-07-11 Norsk Hydro As Polypeptides
ES2527946T3 (es) * 2003-03-05 2015-02-02 Dendreon Corporation Composiciones y métodos que emplean polipéptidos de marco de lectura alternativa para el tratamiento de cáncer y enfermedades infecciosas
EP1748067A1 (en) * 2005-07-29 2007-01-31 Institut Pasteur Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
US10767167B2 (en) 2005-07-29 2020-09-08 Institut Pasteur Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
US20090202499A1 (en) * 2006-01-19 2009-08-13 The Regents Of The University Of California Human Telomerase Reverse Transcriptase Peptides
US9732131B2 (en) 2006-02-27 2017-08-15 Calviri, Inc. Identification and use of novopeptides for the treatment of cancer
WO2008010010A1 (en) * 2006-07-12 2008-01-24 Vaxon Biotech Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy
EP1887084A1 (en) * 2006-08-10 2008-02-13 International Investment and Patents SA Plasmids with immunological action
JP5207354B2 (ja) * 2008-03-12 2013-06-12 独立行政法人産業技術総合研究所 転写抑制ペプチド及びその遺伝子
CA2727388C (en) * 2008-06-16 2017-08-29 Genovax S.R.L. Telomerase-derived peptides for use in treatment of cancer
WO2010037395A2 (en) * 2008-10-01 2010-04-08 Dako Denmark A/S Mhc multimers in cancer vaccines and immune monitoring
GB0821616D0 (en) 2008-11-26 2008-12-31 Lytix Biopharma As Compounds
US9018352B2 (en) 2009-11-10 2015-04-28 Allegro Pharmaceuticals, Inc. Peptide compositions and therapeutic uses thereof
US11673914B2 (en) 2009-11-10 2023-06-13 Allegro Pharmaceuticals, LLC Peptide therapies for reduction of macular thickening
EP2536830B1 (en) 2010-02-16 2019-07-17 Ultimovacs AS Polypeptides
FR2960542B1 (fr) 2010-05-27 2012-08-17 Esther Suzy Arlette Fellous Peptide en tant que medicament, en particulier pour le traitement du cancer
WO2012154894A2 (en) * 2011-05-09 2012-11-15 Allegro Pharmaceuticals, Inc. Integrin receptor antagonists and their methods of use
EP2847213B1 (en) * 2012-05-11 2018-01-03 KAEL-GemVax Co.,Ltd Anti-inflammatory peptides and composition comprising the same
KR102578891B1 (ko) * 2012-05-11 2023-09-15 주식회사 젬백스앤카엘 항염증 활성을 갖는 펩티드 및 이를 포함하는 조성물
US9844584B2 (en) 2012-05-11 2017-12-19 Gemvax & Kael Co., Ltd. Composition for preventing or treating sepsis
EP2873678B1 (en) * 2012-07-11 2024-06-26 Gemvax & Kael Co.,Ltd Conjugate comprising a cell-penetrating peptide and compositions comprising same
US20150125438A1 (en) 2012-07-20 2015-05-07 Sang Jae Kim Anti-Inflammatory Peptides and Composition Comprising the Same
EP2899201B1 (en) 2012-09-19 2019-09-11 Gemvax & Kael Co., Ltd. Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
EP2899199B1 (en) * 2012-09-19 2019-07-03 Gemvax & Kael Co., Ltd. Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
TWI616530B (zh) * 2012-09-19 2018-03-01 傑姆維克斯＆凱爾有限公司 穿膜胜肽以及包含該胜肽之共軛物及組成物（一）
KR102038487B1 (ko) 2012-09-19 2019-10-30 주식회사 젬백스앤카엘 텔로머라제 펩티드를 포함하는 항균 또는 항진균용 조성물
WO2014046478A1 (ko) * 2012-09-19 2014-03-27 주식회사 카엘젬백스 세포 투과성 펩티드, 그를 포함한 컨쥬게이트 및 그를 포함한 조성물
KR102166542B1 (ko) 2012-09-28 2020-10-16 주식회사 젬백스앤카엘 줄기세포 검출을 위한 텔로머라제 유래 펩티드 및 조영물질의 컨쥬게이트 및 이를 포함하는 조영제
CN102875657B (zh) * 2012-10-22 2014-04-09 南京工业大学 一种制备端粒酶多肽疫苗的方法
KR102093093B1 (ko) 2012-12-13 2020-03-25 주식회사 젬백스앤카엘 피부 노화 개선용 조성물
KR102106756B1 (ko) 2012-12-13 2020-05-06 주식회사 젬백스앤카엘 자외선에 의한 피부 손상 예방 또는 치료용 조성물
WO2014171792A1 (ko) * 2013-04-19 2014-10-23 주식회사 카엘젬백스 허혈성 손상 치료 및 예방용 조성물
KR102275912B1 (ko) * 2013-05-03 2021-07-12 주식회사 젬백스앤카엘 Hsp 발현 억제 펩티드 및 이를 포함하는 조성물
CA2912557A1 (en) * 2013-06-07 2014-12-11 Gemvax & Kael Co., Ltd. Biological markers useful in cancer immunotherapy
ES2808076T3 (es) * 2013-06-21 2021-02-25 Gemvax & Kael Co Ltd Regulador de la secreción hormonal, composición que lo contiene y procedimiento para controlar la secreción hormonal mediante su uso
EP3020724A4 (en) * 2013-07-12 2017-01-18 Gemvax & Kael Co., Ltd. Cell-penetrating peptide and conjugate comprising same
KR102204476B1 (ko) * 2013-08-14 2021-01-19 주식회사 젬백스앤카엘 다발성 경화증 치료 및 예방용 조성물
GB201315946D0 (en) * 2013-09-06 2013-10-23 Immune Targeting Systems Its Ltd Oncology vaccine
EP3061459B1 (en) * 2013-10-23 2019-12-11 Gemvax & Kael Co., Ltd. Composition for treating and preventing benign prostatic hyperplasia
WO2015076621A1 (ko) 2013-11-22 2015-05-28 주식회사 카엘젬백스 혈관 신생 억제 활성을 가지는 펩티드 및 이를 포함하는 조성물
KR102106757B1 (ko) * 2013-11-29 2020-05-06 주식회사 젬백스앤카엘 난소 동결 보존용 펩티드 및 이를 포함하는 조성물
KR102667428B1 (ko) * 2013-12-10 2024-05-21 주식회사 젬백스앤카엘 항산화 효과를 가지는 펩티드 및 이를 포함하는 조성물
EP3085380B1 (en) * 2013-12-17 2020-06-17 Gemvax & Kael Co., Ltd. Composition for treating prostate cancer
KR102166549B1 (ko) 2014-01-10 2020-10-16 주식회사 젬백스앤카엘 혈뇌장벽 투과성 펩티드 및 이를 포함하는 컨쥬게이트
KR101503341B1 (ko) * 2014-03-12 2015-03-18 국립암센터 자가암항원 특이적 cd8+ t 세포의 분리 및 증식방법
WO2015156649A1 (ko) * 2014-04-11 2015-10-15 주식회사 젬백스앤카엘 섬유증 억제 활성을 가지는 펩티드 및 이를 포함하는 조성물
ES2962532T3 (es) 2014-04-30 2024-03-19 Gemvax & Kael Co Ltd Composición para el trasplante de órganos, tejidos o células, kit y procedimiento de trasplante
WO2015170790A1 (ko) * 2014-05-09 2015-11-12 주식회사 카엘젬백스 허혈성 손상 치료 및 예방용 조성물
CN105601715B (zh) * 2014-05-29 2019-10-01 河北医科大学第一医院 一种治疗癌症的肽变体及其应用
KR102166543B1 (ko) 2014-06-02 2020-10-16 주식회사 젬백스앤카엘 켈로이드 억제용 조성물 및 그 억제 방법
KR102413243B1 (ko) * 2014-12-23 2022-06-27 주식회사 젬백스앤카엘 안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물
KR102397510B1 (ko) * 2014-12-23 2022-05-13 주식회사 젬백스앤카엘 난소 기능 보존용 펩티드 및 이를 포함하는 조성물
ES2799511T3 (es) * 2015-02-27 2020-12-18 Gemvax & Kael Co Ltd Péptido para prevenir la pérdida de audición, y composición que lo comprende
EP3305802B1 (en) 2015-05-26 2021-05-12 Gemvax & Kael Co., Ltd. Anti-inflammatory, anti-fibrotic and wound-healing octapeptides and compositions containing the same
KR102638286B1 (ko) * 2015-07-02 2024-02-20 주식회사 젬백스앤카엘 항바이러스 활성 효능을 가지는 펩티드 및 이를 포함하는 조성물
KR20170054310A (ko) * 2015-11-09 2017-05-17 주식회사 젬백스앤카엘 텔로머라제 유래 펩티드를 포함하는 수지상세포 치료제 및 면역 치료제, 및 이를 사용하는 치료방법
CN117018162A (zh) 2016-04-07 2023-11-10 珍白斯凯尔有限公司 具有增加端粒酶活性和延长端粒的效果的肽以及组合物
ES2905890T3 (es) 2017-01-06 2022-04-12 Eutilex Co Ltd Anticuerpos anti-4-1BB humano y usos de los mismos
EP3576764A4 (en) 2017-02-03 2020-12-16 The Medical College of Wisconsin, Inc. KRAS PEPTIDE VACCINE COMPOSITIONS AND METHOD OF USE
JP2020522480A (ja) 2017-06-02 2020-07-30 アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ 個別化された犬用癌ワクチンを作製する方法
WO2019055618A1 (en) 2017-09-15 2019-03-21 Arizona Board Of Regents On Behalf Of Arizona State University METHODS OF CLASSIFYING RESPONSES TO ANTICANCER IMMUNOTHERAPY
WO2020002650A1 (en) 2018-06-29 2020-01-02 Targovax Asa A formulation
WO2021067550A1 (en) 2019-10-02 2021-04-08 Arizona Board Of Regents On Behalf Of Arizona State University Methods and compositions for identifying neoantigens for use in treating and preventing cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103974D0 (en) 1991-02-26 1991-04-10 Norsk Hydro As Therapeutically useful peptides or peptide fragments
AU710783B2 (en) 1994-06-14 1999-09-30 Board Of Trustees Of The Leland Stanford Junior University Methods for in vivo T cell activation by antigen-pulsed dendritic cells
US5968506A (en) 1995-08-04 1999-10-19 Geron Corporation Purified telomerase
DE69716240T2 (de) * 1996-02-12 2003-06-26 Ml Lab Plc London Neue methode zur impfung sowie impfstoffe dafür, die eine epitopkodierende nukleinsäure und ein epitopenthaltende peptid beinhalten
BR9708387A (pt) 1996-03-28 2000-01-04 Genitrix Llc Processo para vacinação de um mamìfero a um antìgeno selecionado, células patogênica e hospedeira, composição de vacina, ácido nucleico, e, opsonina engenheirada.
US5770422A (en) 1996-07-08 1998-06-23 The Regents Of The University Of California Human telomerase
PT910598E (pt) * 1996-07-08 2005-08-31 Vivoxyd Oy Material biodegradavel com elevada forca de impacto
DE19743497A1 (de) 1996-10-01 1998-08-20 Geron Corp Katalytische Untereinheit menschlicher Telomerase
US7390891B1 (en) 1996-11-15 2008-06-24 Amgen Inc. Polynucleotides encoding a telomerase component TP2
US6337200B1 (en) 1998-03-31 2002-01-08 Geron Corporation Human telomerase catalytic subunit variants
AU3456099A (en) 1998-03-31 1999-10-18 Geron Corporation Methods and compositions for eliciting an immune response to a telomerase antigen

Also Published As

Publication number Publication date
ES2341170T5 (es) 2014-09-09
NO983141L (no) 2000-01-10
EP2316476B1 (en) 2015-11-25
US7030211B1 (en) 2006-04-18
DE69942072D1 (de) 2010-04-08
ATE458494T1 (de) 2010-03-15
EP2258383A2 (en) 2010-12-08
PL203815B1 (pl) 2009-11-30
JP4618657B2 (ja) 2011-01-26
AR077576A2 (es) 2011-09-07
DK1093381T4 (da) 2009-09-21
JP5491315B2 (ja) 2014-05-14
EP1362597B2 (en) 2014-06-25
EP1093381B1 (en) 2003-08-20
PL345541A1 (en) 2001-12-17
PT1362597E (pt) 2010-04-14
CZ303215B6 (cs) 2012-05-30
EP1362597A1 (en) 2003-11-19
CA2336743A1 (en) 2000-01-20
HK1039068A1 (en) 2002-04-12
JP2002520293A (ja) 2002-07-09
EP1362597B1 (en) 2010-02-24
AU756094B2 (en) 2003-01-02
JP2010252810A (ja) 2010-11-11
AR020601A1 (es) 2002-05-22
ES2200526T3 (es) 2004-03-01
US20060106196A1 (en) 2006-05-18
CN100376290C (zh) 2008-03-26
PT1093381E (pt) 2004-01-30
EP2316476A3 (en) 2011-09-14
HUP0104889A2 (hu) 2002-04-29
WO2000002581A1 (en) 2000-01-20
CY1109978T1 (el) 2014-09-10
DE69910580D1 (de) 2003-09-25
EP2258383B1 (en) 2016-03-09
ES2200526T5 (es) 2009-12-11
AU4534099A (en) 2000-02-01
HU230007B1 (en) 2015-04-28
US7794723B2 (en) 2010-09-14
CA2748996A1 (en) 2000-01-20
ES2341170T3 (es) 2010-06-16
CZ200137A3 (en) 2001-06-13
DE69910580T3 (de) 2009-11-26
ATE247484T1 (de) 2003-09-15
TWI261617B (en) 2006-09-11
DE69910580T2 (de) 2004-06-24
EP2316476A2 (en) 2011-05-04
NO313834B1 (no) 2002-12-09
HK1039068B (zh) 2009-02-06
CN1313773A (zh) 2001-09-19
EP1093381B2 (en) 2009-07-22
EP2258383A3 (en) 2011-05-11
CA2336743C (en) 2011-10-11
EP1093381A1 (en) 2001-04-25
HUP0104889A3 (en) 2004-04-28
DK1362597T3 (da) 2010-06-14

Similar Documents

Publication Publication Date Title
DK1093381T3 (da) Antigene peptider afledt fra teleromerase
NO982097D0 (no) Peptider
NO982098L (no) Peptider
ATE347600T1 (de) Gruppe b-streptococcus antigene
DE69907954D1 (de) Gasverdichter
NO20003302L (no) Vaksine
DE69701649T2 (de) Abgasreiniger
DE69908061D1 (de) Gaserzeugungseinrichtung
NO20006191D0 (no) Vaksine
DE69915415D1 (de) Gasfeder
DE69934074D1 (de) Gaserzeugungssystem
DE19982982T1 (de) Kombinierter Gassensor
DE69801257T2 (de) Abgasreiniger
DE69833023D1 (de) Luftreiniger
DE59712136D1 (de) Scheinwerfer-Reinigungseinrichtung
DE69825615D1 (de) Gaseinführung
NO20005599L (no) Vaksine
DE60042130D1 (de) Neue antigene hev-peptide und methoden
GB0115428D0 (en) Antibodies, peptides, analogs and uses thereof
NO20012283D0 (no) Koblede peptider
PT1015447E (pt) Derivado piperidinilmetiloxazolidinona
IL147093A0 (en) Retro-inverso peptides derived from interleukin-3
NO996412D0 (no) Antigene peptider
SE9802536D0 (sv) Novel peptides
KR970027220U (ko) 공기 청정기